Serum Levels of MMPs and TIMP-1 in Patients with Influenza-Virus-associated Encephalopathy

Guozhu Sun
2005-01-01
Abstract:Objective: To evaluate the role of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase-1(TIMP-1)in the pathogenesis of influenza-virus-associated encephalopathy (Flu encephalopathy). Methods:We measured MMP-2, MMP-9, and TIMP-1 levels in serum samples of 22 patients with Flu encephalopathy by using the enzyme-linked-immunosorbent assay (ELISA). The results were compared with those of 20 age-matched patients with influenza virus infection without encephalopathy and 22 age-matched patients with noninfectious neurologic diseases. Results:The levels of MMP-9 were eminently elevated in patients with influenza and Flu encephalopathy compared with the control group. Howerer, no difference was found in MMP-9 between patients with influenza and Flu encephalopathy. The MMP-2 was eminently decreased in patients with influenza and Flu encephalopathy compared with the control group (P0.05). There was significant difference in MMP-2 level between patients with influenza and Flu encephalopathy. Although the level of TIMP-1 in patients with Flu encephalopathy was significantly higher than that in control group, the TIMP-1 was not significantly up-regulated in patients with Flu encephalopathy compared with influenza group (P0.05). The ratio of MMP-9 to TIMP-1 ratio, a measure of proteolytic capacity, was strongly increased in patients with Flu encephalopathy and influenza. Conclusion:The investigations of serum samples of patients with Flu encepholopathy revealed the increase of MMP-9 and decrease of MMP-2, suggesting that MMPs may be involved in the pathophysiology of Flu encepholopathy in humans.
What problem does this paper attempt to address?